Gilead Sciences | Işletim Giderleri



Operating Expenses Değişiklik Tarih
AbbVie USD 9.61B 6.98B 2025-03
Agios Pharmaceuticals USD 135.77M 1.11B 2024-12
ALKERMES USD 267.3M 6.09M 2024-12
Alnylam Pharmaceuticals USD 698.32M 120.5M 2024-12
Amgen USD 6.78B 401M 2024-12
Biogen USD 2.01B 13.3M 2024-12
BioMarin Pharmaceutical USD 585.91M 45.94M 2024-12
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Glaxosmithkline GBP 7.42B 408M 2024-12
Incyte USD 847.73M 29.46M 2025-03
J&J USD 8.26B 10.37B 2025-03
Merck USD 9.66B 1.67B 2025-03
Moderna USD 1.16B 1.06B 2025-03
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
Novartis USD 11.28B 1.73B 2024-12
Pfizer USD 10.05B 8.12B 2025-03
PTC Therapeutics USD 275.66M 24.36M 2024-12
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Sanofi EUR 8.32B 1.55B 2025-03
Sarepta Therapeutics USD 496.73M 51.76M 2024-12
United Therapeutics USD 411.6M 33.4M 2025-03
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



Gilead Sciences Işletim Giderleri - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - May 2025.